|
B3GNT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.415600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.784000E-04 |
| Normal-vs-Stage2 |
1.55160000003818E-06 |
| Normal-vs-Stage3 |
8.623600E-03 |
| Normal-vs-Stage4 |
3.883700E-02 |
| Stage1-vs-Stage2 |
3.981600E-03 |
| Stage1-vs-Stage3 |
2.520000E-01 |
| Stage1-vs-Stage4 |
3.186200E-01 |
| Stage2-vs-Stage3 |
1.115920E-03 |
| Stage2-vs-Stage4 |
7.124600E-03 |
| Stage3-vs-Stage4 |
9.148600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.021950E-03 |
| Normal-vs-AfricanAmerican |
1.153000E-01 |
| Normal-vs-Asian |
3.61819999999957E-05 |
| Caucasian-vs-AfricanAmerican |
7.029000E-01 |
| Caucasian-vs-Asian |
5.284300E-03 |
| AfricanAmerican-vs-Asian |
6.170300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.303400E-03 |
| Normal-vs-Female |
5.444700E-04 |
| Male-vs-Female |
5.116000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.743690E-03 |
| Normal-vs-Age(41-60Yrs) |
1.595020E-04 |
| Normal-vs-Age(61-80Yrs) |
5.752100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.564200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.042600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.167400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.051600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.991650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.166100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.250200E-01 |
| Classical-VS-Follicular |
3.0731994726807E-10 |
| Classical-VS-Other |
8.667400E-01 |
| Classical-VS-Normal |
1.053680E-02 |
| Tall-VS-Follicular |
3.621300E-03 |
| Tall-VS-Other |
9.643200E-01 |
| Tall-VS-Normal |
1.079760E-01 |
| Follicular-VS-Other |
1.204450E-02 |
| Follicular-VS-Normal |
8.70869999447521E-08 |
| Other-VS-Normal |
3.616600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.41780000001624E-06 |
| Normal-vs-N1 |
6.342000E-03 |
| N0-vs-N1 |
1.341680E-02 |
|
|
